Breaking News Instant updates and real-time market news.

BIIB

Biogen

$292.64

0.17 (0.06%)

, UAL

United Continental

$67.23

-0.94 (-1.38%)

10:41
03/16/17
03/16
10:41
03/16/17
10:41

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Biogen (BIIB) was downgraded to Equal Weight from Overweight at Morgan Stanley and Market Perform from Outperform at Leerink. 2. United Continental (UAL) downgraded to In Line from Outperform at Evercore ISI. 3. Tyson Foods (TSN) downgraded to Hold from Buy at Argus with analyst John Staszak citing the SEC probe of Tyson and other poultry producers, potential decelerating earnings in coming quarters, and a recent bird flu outbreak in two states. 4. Williams-Sonoma (WSM) downgraded to Market Perform from Outperform at William Blair with analyst Daniel Hofkin citing the company's fourth quarter results. 5. Inovio (INO) downgraded to Neutral from Overweight at Piper Jaffray with analyst Charles Duncan saying a "lack of focus and advancement for any one program" poses execution risk to the broader platform, and to shareholders. The analyst lowered his price target for the shares to $9 from $13 following the company's Q4 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

BIIB

Biogen

$292.64

0.17 (0.06%)

UAL

United Continental

$67.23

-0.94 (-1.38%)

TSN

Tyson Foods

$62.08

-1.02 (-1.62%)

WSM

Williams-Sonoma

$49.47

1.35 (2.81%)

INO

Inovio

$6.87

0.26 (3.93%)

  • 19

    Mar

  • 20

    Mar

  • 20

    Jun

BIIB Biogen
$292.64

0.17 (0.06%)

03/16/17
MSCO
03/16/17
DOWNGRADE
Target $305
MSCO
Equal Weight
Biogen downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Matthew Harrison downgraded Biogen to Equal Weight and lowered his price target for the shares to $305 from $369.
03/16/17
03/16/17
DOWNGRADE
Target $300

Market Perform
Biogen downgraded to Market Perform at Leerink
As previously reported, Leerink analyst Geoffrey Porges downgraded Biogen to Market Perform from Outperform based on a slower than expected ramp for Spinraza, and the completion of the series of important catalysts that have evolved over the last few months. The analyst is not particularly positive about the other programs in Biogen's late stage pipeline such as BIIB074, BIIB059, STX100 and opicinumab. Porges also lowered his price target on the shares to $300 from $305.
03/16/17
03/16/17
DOWNGRADE

Equal Weight
Biogen cut to Equal Weight as Alzheimer's data awaited at Morgan Stanley
As previously reported, Morgan Stanley analyst Matthew Harrison downgraded Biogen to Equal Weight from Overweight and lowered his price target for the shares to $305 from $369, saying that he sees limited upside for the stock in the near-term. The analyst said his rating change was "not a downside call, but a timing call" as he continues to have a positive view of Alzheimer's candidate aducanumab, though its data is not due until the second half of 2019. In arriving at his $305 price target, Harrison attributes $235 for the base business and $70 per share for aducanumab.
03/16/17
LEER
03/16/17
DOWNGRADE
Target $300
LEER
Market Perform
Biogen downgraded to Market Perform from Outperform at Leerink
UAL United Continental
$67.23

-0.94 (-1.38%)

03/13/17
UBSW
03/13/17
NO CHANGE
UBSW
Buy
Weakness in airline sector a buying opportunity, says UBS
UBS analyst Darryl Genovisi said the recent dip in airline shares provides a buying opportunity. The analyst noted most of the airlines have cut their PRASM guidance for Q1 and with the miss already priced in and a better outlook for Q2, investors should be buyers of the group. Genovisi prefers United Continental (UAL) followed by Delta (DAL) and Southwest (LUV).
03/16/17
EVER
03/16/17
DOWNGRADE
EVER
In Line
United Continental downgraded to In Line from Outperform at Evercore ISI
Evercore ISI analyst Duane Pfennigwerth downgraded United Continental to In Line.
02/22/17
02/22/17
NO CHANGE

Morgan Stanley would not dismiss possibility of Berkshire buying an airline
With Warren Buffett's Berkshire Hathaway (BRK.A) recently disclosing an increase to its overall airline exposure, making the firm a number one or two holder for each of the "Big 4," Morgan Stanley polled investors and found that about 60% do not expect this to be a step towards a full-scale acquisition. However, analyst Rajeev Lalwani said the prospect of Berkshire buying an airline is a possibility that is "not worth dismissing," citing the historical precedent of Buffett's involvement in the rail industry and eventual deal to buy Burlington Northern SantaFe in 2009. The top four U.S. airlines include American Airlines (AAL), Delta Air Lines (DAL), Southwest (LUV) and United Continental (UAL).
01/05/17
01/05/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Macy's (M) downgraded to Hold from Buy at Deutsche Bank with analyst Paul Trussell saying the company's turnaround initiatives "continue to fall short of expectations." The "discouraging" 2017 forecast reflects the "realities of market share losses" to off-price retail, Amazon (AMZN) and other online threats, Trussell tells investors in a research note after Macy's lowered its outlook. He cut his price target for the shares to $34 from $47. 2. Kohl's (KSS) downgraded to Market Perform from Outperform at Telsey Advisory and to Neutral from Outperform at Baird. 3. DCP Midstream (DPM) downgraded to Sector Perform from Outperform at RBC Capital and to Underperform from Neutral at Credit Suisse. 4. United Continental (UAL) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Rajeev Lalwani saying he changed his rating due to relative outperformance and said further upside might be limited from here. 5. Travelers (TRV) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Kai Pan saying lower reserve releases and rising auto claims present a risk to earnings and post US election share strength underestimates these fundamental headwinds. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
TSN Tyson Foods
$62.08

-1.02 (-1.62%)

02/07/17
JEFF
02/07/17
NO CHANGE
Target $75
JEFF
Buy
Tyson Foods price-fixing allegations unfounded, says Jefferies
Jefferies analyst Akshay Jagdale attributes yesterday's pullback in shares of Tyson Foods to concerns about the newly disclosed SEC investigation and ongoing worries about peaking margins. The SEC investigation represents a short-term overhang but Beef and Pork margins will eventually normalize, Jagdale tells investors in a post-earnings research note. The analyst believes the chicken price-fixing allegations are unfounded. He keeps a Buy rating on Tyson's with a $75 price target. The company's "value-added earnings stream remains significantly undervalued," Jagdale writes.
03/16/17
ARGS
03/16/17
DOWNGRADE
ARGS
Hold
Tyson Foods downgraded on probe, earnings outlook, bird flu at Argus
As noted earlier, Argus downgraded Tyson Foods to Hold from Buy. As reasons for the downgrade, analyst John Staszak cited the SEC probe of Tyson and other poultry producers, potential decelerating earnings in coming quarters, and a recent bird flu outbreak in two states.
03/16/17
ARGS
03/16/17
DOWNGRADE
ARGS
Hold
Tyson Foods downgraded to Hold from Buy at Argus
12/02/16
KEYB
12/02/16
INITIATION
KEYB
Overweight
Tyson Foods initiated at KeyBanc
As noted earlier, KeyBanc initiated Tyson Foods with a $70 price target and an Overweight rating. The firm says that concerns about the company are "overdone," while the shares have reached an attractive entry point. It thinks that the company's "significant branded momentum and solid free cash flow" should enable it to carry out share repurchases and potentially make acquisitions. The firm is upbeat on the company's outlook.
WSM Williams-Sonoma
$49.47

1.35 (2.81%)

03/13/17
FBCO
03/13/17
NO CHANGE
Target $44
FBCO
Neutral
Williams-Sonoma price target lowered to $44 from $50 at Credit Suisse
Credit Suisse analyst Seth Sigman lowered his price target for Williams-Sonoma to $44 from $50 ahead of Q4 results. Over the next year, the analyst believes that the combination of sluggish comps, incremental gross margin pressures from shipping and discounting, and higher investments will pressure EPS more than expected. He reiterates a Neutral rating on the shares.
03/16/17
WBLR
03/16/17
DOWNGRADE
WBLR
Market Perform
Williams-Sonoma downgraded to Market Perform from Outperform at William Blair
William Blair analyst Daniel Hofkin downgraded Williams-Sonoma to Market Perform following the company's Q4 results.
02/13/17
TLSY
02/13/17
DOWNGRADE
Target $51
TLSY
Market Perform
Williams-Sonoma downgraded to Market Perform at Telsey Advisory
As previously reported, Telsey Advisory downgraded Williams-Sonoma to Market Perform from Outperform, as analyst Cristina Fernandez said the company is fighting a more competitive environment and softer consumer spending by aggressively increasing promotions to maintain share. The analyst is surprised by the high level of promotions at West Elm and said some real estate contacts have noted softening store sales in December. The analyst, who also said the turnaround at Pottery Barn could take longer and sees limited margin expansion in 2017, decreased her price target on the stock to $51 from $61.
02/13/17
02/13/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Boeing (BA) downgraded to Underperform from Neutral at Buckingham with the firm saying at current levels, shares are priced for perfection and reflect optimistic free-cash-flow estimates. The firm's analyst expects Boeing shares to underperform on downward estimate revisions, a series of negative catalysts, and multiple compression. 2. Reynolds American (RAI) downgraded to Sector Perform from Outperform at RBC Capital. 3. Occidental Petroleum (OXY) downgraded to Neutral from Buy at Mizuho with analyst Timothy Rezvan citing valuation, muted dividend growth, and increasing unit expense trends. 4. AK Steel (AKS) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Evan Kurtz saying he is concerned about AK's exposure to electrical steel and heavy auto steel, which could prove to be headwinds this year. 5. Williams-Sonoma (WSM) downgraded to Market Perform from Outperform at Telsey Advisory with analyst Cristina Fernandez saying the company is fighting a more competitive environment and softer consumer spending by aggressively increasing promotions to maintain share. The analyst is surprised by the high level of promotions at West Elm and said some real estate contacts have noted softening store sales in December. Fernandez said the turnaround at Pottery Barn could take longer and sees limited margin expansion in 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
INO Inovio
$6.87

0.26 (3.93%)

03/16/17
MAXM
03/16/17
UPGRADE
Target $10
MAXM
Buy
Inovio upgraded to Buy from Hold at Maxim
Maxim analyst Jason McCarthy upgraded Inovio to Buy from Hold and set a $10 price target on the stock, stating that it has multiple earlier stage programs moving forward with more significant data points coming in 2017 while it moves closer to its pivotal study in cervical dysplasia. He notes that his model assumes that VGX-3100 is commercialized in 2021 for cervical dysplasia.
11/07/16
AGIS
11/07/16
INITIATION
Target $12
AGIS
Buy
Inovio initiated with a Buy at Aegis
Aegis analyst Jason Wittes initiated Inovio with Buy and a $12 price target.
03/16/17
03/16/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Oracle (ORCL) was upgraded to Market Perform from Underperform at JMP Securities and to Overweight from Neutral at JPMorgan. 2. GoPro (GPRO) upgraded to Neutral from Sell at Citi with analyst Stanley Kovler saying the recent stabilization in revenue as well as the company's "significant" restructuring initiatives accelerate its path to profitability to 2017 from 2019. These developments should, at the very least, stave off the bear scenario for a few quarters, Kovler tells investors in a research note. He raised his price target for GoPro shares to $9 from $8. 2. TJX (TJX) upgraded to Conviction Buy from Buy at Goldman with analyst Matthew Fassler saying the company offers long-term secular growth along with near-term catalysts. The analyst expects TJX to grow market share at the expense of department stores. 4. Inovio (INO) upgraded to Buy from Hold at Maxim with analyst Jason McCarthy saying it has multiple earlier stage programs moving forward with more significant data points coming in 2017 while it moves closer to its pivotal study in cervical dysplasia. He notes that his model assumes that VGX-3100 is commercialized in 2021 for cervical dysplasia. 5. Quest Diagnostics (DGX) upgraded to Neutral from Underperform at BofA/Merrill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/16/17
PIPR
03/16/17
DOWNGRADE
Target $9
PIPR
Neutral
Inovio downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Charles Duncan downgraded Inovio to Neutral saying a "lack of focus and advancement for any one program" poses execution risk to the broader platform, and to shareholders. The analyst lowered his price target for the shares to $9 from $13 following the company's Q4 results.

TODAY'S FREE FLY STORIES

UTX

United Technologies

$117.87

2.61 (2.26%)

13:27
08/16/17
08/16
13:27
08/16/17
13:27
Hot Stocks
United Technologies CEO Hayes tenders resignation from council »

In a statement, United…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXMD

TherapeuticsMD

$6.03

0.21 (3.61%)

13:25
08/16/17
08/16
13:25
08/16/17
13:25
Options
TherapeuticsMD call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

CSCO

Cisco

$32.09

0.25 (0.79%)

, ANET

Arista Networks

$174.47

3.88 (2.27%)

13:21
08/16/17
08/16
13:21
08/16/17
13:21
Earnings
On The Fly: What to watch for in Cisco's earnings report »

Cisco (CSCO) is scheduled…

CSCO

Cisco

$32.09

0.25 (0.79%)

ANET

Arista Networks

$174.47

3.88 (2.27%)

AAPL

Apple

$161.60

1.75 (1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 16

    Aug

  • 16

    Aug

  • 17

    Aug

  • 23

    Aug

  • 06

    Sep

$NSD

NASDAQ Market Internals

13:17
08/16/17
08/16
13:17
08/16/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$32.26

-0.0009 (-0.00%)

, BLK

BlackRock

$428.45

0.2 (0.05%)

13:16
08/16/17
08/16
13:16
08/16/17
13:16
Hot Stocks
Trump says ending Manufacturing Council, Strategic & Policy Forum »

President Donald Trump…

BX

Blackstone

$32.26

-0.0009 (-0.00%)

BLK

BlackRock

$428.45

0.2 (0.05%)

IBM

IBM

$142.60

0.53 (0.37%)

MMM

3M

$207.83

0.645 (0.31%)

INTC

Intel

$36.00

-0.34 (-0.94%)

UAA

Under Armour

$18.29

0.07 (0.38%)

UA

Under Armour

$16.75

0.09 (0.54%)

MRK

Merck

$62.70

0.2 (0.32%)

CPB

Campbell Soup

$53.92

0.19 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 06

    Sep

  • 06

    Sep

  • 08

    Sep

  • 22

    Sep

  • 03

    Oct

  • 04

    Oct

$NYE

NYSE Market Internals

13:16
08/16/17
08/16
13:16
08/16/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$10.81

-0.0337 (-0.31%)

13:08
08/16/17
08/16
13:08
08/16/17
13:08
Periodicals
DHL, Ford unveil jointly manufactured electric delivery vehicle, AP reports »

DHL Group Ford have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$32.30

0.04 (0.12%)

, GM

General Motors

$35.68

0.135 (0.38%)

13:05
08/16/17
08/16
13:05
08/16/17
13:05
Hot Stocks
Forum CEOs: Yesterday's press conference was 'point of no return,' Coombs tweets »

CNBC's Bertha Coombs…

BX

Blackstone

$32.30

0.04 (0.12%)

GM

General Motors

$35.68

0.135 (0.38%)

JPM

JPMorgan

$92.76

0.03 (0.03%)

BLK

BlackRock

$428.72

0.47 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Sep

  • 11

    Sep

  • 12

    Oct

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

HBNC

Horizon Bancorp

$25.84

-0.2 (-0.77%)

13:01
08/16/17
08/16
13:01
08/16/17
13:01
Hot Stocks
Horizon Bancorp, Lafatyette Community Bancorp receive regulatory approvals »

Horizon Bancorp and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBI

CB&I

$10.47

-0.72 (-6.43%)

13:00
08/16/17
08/16
13:00
08/16/17
13:00
Options
Notable put spread in Chicago Bridge and Iron as shares tumble »

Notable put spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPB

Campbell Soup

$53.94

0.21 (0.39%)

12:56
08/16/17
08/16
12:56
08/16/17
12:56
Hot Stocks
Campbell Soup CEO resigns from President Trump's council »

Campbell Soup Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$92.68

0.475 (0.52%)

12:56
08/16/17
08/16
12:56
08/16/17
12:56
Hot Stocks
Procter & Gamble: Trian offering 'no new, actionable ideas' to drive value »

The Procter & Gamble…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$32.30

0.04 (0.12%)

, BLK

BlackRock

$429.21

0.96 (0.22%)

12:55
08/16/17
08/16
12:55
08/16/17
12:55
Periodicals
Trump's Strategic and Policy Forum to disband, CNBC says »

President Donald…

BX

Blackstone

$32.30

0.04 (0.12%)

BLK

BlackRock

$429.21

0.96 (0.22%)

IBM

IBM

$142.81

0.744 (0.52%)

MMM

3M

$207.94

0.76 (0.37%)

INTC

Intel

$36.00

-0.34 (-0.94%)

UAA

Under Armour

$18.26

0.0402 (0.22%)

UA

Under Armour

$16.77

0.105 (0.63%)

MRK

Merck

$62.87

0.37 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 06

    Sep

  • 06

    Sep

  • 08

    Sep

  • 22

    Sep

  • 03

    Oct

  • 04

    Oct

UIS

Unisys

$8.23

0.225 (2.81%)

12:55
08/16/17
08/16
12:55
08/16/17
12:55
Conference/Events
Unisys to host webinar »

SVP & CTO El-Sadany…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 08

    Sep

AROW

Arrow Financial

$32.05

-0.55 (-1.69%)

12:53
08/16/17
08/16
12:53
08/16/17
12:53
Hot Stocks
Arrow Financial names Edward Campanella CFO »

Arrow Financial …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$32.30

0.041 (0.13%)

, BLK

BlackRock

$429.20

0.95 (0.22%)

12:52
08/16/17
08/16
12:52
08/16/17
12:52
Hot Stocks
Breaking Hot Stocks news story on Blackstone, BlackRock, IBM, 3M, Merck, Intel, Under Armour, Under Armour »

Trump's Strategic…

BX

Blackstone

$32.30

0.041 (0.13%)

BLK

BlackRock

$429.20

0.95 (0.22%)

IBM

IBM

$142.81

0.742 (0.52%)

MMM

3M

$208.11

0.93 (0.45%)

MRK

Merck

$62.90

0.4 (0.64%)

INTC

Intel

$36.00

-0.34 (-0.94%)

UA

Under Armour

$16.78

0.119 (0.71%)

UAA

Under Armour

$18.28

0.055 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 06

    Sep

  • 06

    Sep

  • 08

    Sep

  • 22

    Sep

  • 03

    Oct

  • 04

    Oct

HRG

HRG Group

$15.89

0.1 (0.63%)

12:50
08/16/17
08/16
12:50
08/16/17
12:50
Options
$4.9M call buyer in HRG Group »

$4.9M call buyer in HRG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

AERI

Aerie Pharmaceuticals

$52.40

1.8 (3.56%)

12:45
08/16/17
08/16
12:45
08/16/17
12:45
Periodicals
Aerie approval jeopardized by manufacturing problems, STAT reports »

The FDA's approval…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 28

    Feb

BX

Blackstone

$32.32

0.0566 (0.18%)

, BLK

BlackRock

$429.21

0.96 (0.22%)

12:42
08/16/17
08/16
12:42
08/16/17
12:42
Periodicals
Strategic and Policy Forum members on verge of disbanding, NY Times reports »

Members of President…

BX

Blackstone

$32.32

0.0566 (0.18%)

BLK

BlackRock

$429.21

0.96 (0.22%)

IBM

IBM

$142.61

0.54 (0.38%)

MMM

3M

$208.18

1 (0.48%)

INTC

Intel

$36.00

-0.34 (-0.94%)

UAA

Under Armour

$18.29

0.07 (0.38%)

UA

Under Armour

$16.79

0.13 (0.78%)

MRK

Merck

$62.84

0.34 (0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 06

    Sep

  • 06

    Sep

  • 08

    Sep

  • 22

    Sep

  • 03

    Oct

  • 04

    Oct

AAPL

Apple

$162.42

0.8 (0.49%)

12:41
08/16/17
08/16
12:41
08/16/17
12:41
Periodicals
Ireland says no change to Apple tax policy, Bloomberg reports »

The Irish Finance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

UNH

UnitedHealth

$193.33

-1.17 (-0.60%)

12:40
08/16/17
08/16
12:40
08/16/17
12:40
Recommendations
UnitedHealth analyst commentary  »

UnitedHealth made…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$29.68

0.44 (1.50%)

12:40
08/16/17
08/16
12:40
08/16/17
12:40
Options
20K Micron Sep 33 - 36 call spreads bought for 32c »

20K Micron Sep 33 - 36…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 06

    Sep

12:30
08/16/17
08/16
12:30
08/16/17
12:30
General news
SF Fed says "Good News on Wage Growth," »

SF Fed says "Good…

MMM

3M

$208.13

0.95 (0.46%)

12:29
08/16/17
08/16
12:29
08/16/17
12:29
Hot Stocks
3M CEO resigns President Trump's Manufacturing Jobs Initiative »

3M CEO Inge Thulin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$161.60

1.75 (1.09%)

12:25
08/16/17
08/16
12:25
08/16/17
12:25
Periodicals
Ireland shuns EU petition that it collect EUR 13B from Apple »

According to Reuters,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.